Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

COVID-19 in Polish Ice Swimmers. (ICE)

6. april 2021 oppdatert av: Wroclaw Medical University

Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.

Ice swimming is an increasingly common phenomenon in Poland. It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections. In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments. Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.

The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.

Studietype

Observasjonsmessig

Registrering (Faktiske)

2534

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

  • Polen
    • Dolny Slask
      • Wrocław, Dolny Slask, Polen, 51-618
        • Department of Public Health at Wroclaw Medical University
    • Lubuskie
      • Gorzów Wielkopolski, Lubuskie, Polen, 66-400
        • Department of Radiotherapy of Multidisciplinary Provincial Hospital
      • Zielona Góra, Lubuskie, Polen, 65-031
        • Treasury Medical Company

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn
  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Surveys are distributed en masse among ice swimmers from Poland. Comparative data for the control group is derived from officially published national and regional pandemic data.

Beskrivelse

Inclusion Criteria:

  • ice swimmers

Exclusion Criteria:

  • not active ice swimmers

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Ice Swimmers Group.
No intervention. Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
Annen: Ice Swimming
The intervention is not made in the course of a research study. Ice swimming has been introduced earlier by a given group. The group was made up of people who already swim in ice.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Tidsramme: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Tidsramme: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Tidsramme: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Tidsramme: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Tidsramme: 47 days.
Inference from data obtained from surveys collected among ice swimmers.
47 days.
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Tidsramme: 47 days.
Inference from data obtained from surveys collected among ice swimmers.
47 days.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Tidsramme: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Wroclaw Medical University

Etterforskere

  • Studieleder: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
  • Studieleder: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
  • Studiestol: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
  • Hovedetterforsker: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
  • Hovedetterforsker: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. desember 2020

Primær fullføring (Faktiske)

17. januar 2021

Studiet fullført (Faktiske)

1. mars 2021

Datoer for studieregistrering

Først innsendt

24. mars 2021

Først innsendt som oppfylte QC-kriteriene

25. mars 2021

Først lagt ut (Faktiske)

26. mars 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

9. april 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. april 2021

Sist bekreftet

1. april 2021

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • KB-03/139/2021

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere